1. Home
  2. NRDS vs ABCL Comparison

NRDS vs ABCL Comparison

Compare NRDS & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NerdWallet Inc.

NRDS

NerdWallet Inc.

HOLD

Current Price

$9.91

Market Cap

1.0B

Sector

Technology

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$3.46

Market Cap

910.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NRDS
ABCL
Founded
2009
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
910.0M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
NRDS
ABCL
Price
$9.91
$3.46
Analyst Decision
Buy
Buy
Analyst Count
6
5
Target Price
$14.33
$7.75
AVG Volume (30 Days)
1.1M
3.0M
Earning Date
05-27-2026
05-26-2026
Dividend Yield
N/A
N/A
EPS Growth
68.42
10.91
EPS
0.64
N/A
Revenue
$836,600,000.00
$75,128,000.00
Revenue This Year
$8.80
N/A
Revenue Next Year
$8.14
$16.59
P/E Ratio
$16.20
N/A
Revenue Growth
21.67
160.56
52 Week Low
$7.55
$1.89
52 Week High
$16.24
$6.52

Technical Indicators

Market Signals
Indicator
NRDS
ABCL
Relative Strength Index (RSI) 38.80 48.71
Support Level $8.95 $3.37
Resistance Level $11.39 $3.57
Average True Range (ATR) 0.61 0.22
MACD 0.03 0.02
Stochastic Oscillator 25.22 50.97

Price Performance

Historical Comparison
NRDS
ABCL

About NRDS NerdWallet Inc.

Nerdwallet Inc is a company that provides consumer-driven advice about personal finance through its platform by connecting individuals and small and mid-sized businesses (SMBs) with providers of financial products. It gets revenue from fees paid by its financial services partners in the form of either revenue per action, revenue per click, revenue per lead and revenue per funded loan arrangements.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: